Eukaryotic parasites in the genus Leishmania place approximately 350 million people per year at risk of disease. In addition to their global health significance, Leishmania spp. have served as an important model for delineating basic concepts in immunology such as T-helper cell polarization. There have been many qPCR based assays reported for measuring parasite burden in humans and animals. However, these are largely optimized for use in clinical diagnosis and 25 not specifically for animal models. This has led several of these assays to have suboptimal characteristics for use in animal models. For example, multi-copy number genes have been frequently used to increase sensitivity, but are subject to greater plasticity within the genome and thus may confound effects of experimental manipulations in animal models. In this study, we develop a sybr-green based quantitative touchdown PCR assay for a highly conserved and single 30 copy, putative RNA binding protein, DRBD3. With primers nearly perfectly conserved across all Leishmania spp., this assay rivals the sensitivity of previously reported qPCR based methods of parasite quantitation and successfully detected L. major from mouse infection. Use of this protocol in the future will lead to improved accuracy in animal based models and help to tease apart differences in biology of host-parasite interactions.
Introduction
Parasites in the genus Leishmania cause a spectrum of disease ranging from cutaneous (CL) to visceralizing (VL) disease and are frequently used in many experimental animal models. 40
Up to 1.6 million people each year are infected with one of the forms of leishmaniasis (1) . This significant impact of disease resulted in an estimated 980,000 disability adjusted life years (DALYs) in 2016 (2) . Further, these estimates are likely to significantly underestimate the burden caused by social and psychological stigmatization resulting from long term scarring (3) .
The outcome of Leishmania infection has been understood to depend on proper T-helper 45 (Th) cell polarization since the late 1980's when it was shown that a Th1 response promotes a healing immune response whereas a Th2 response leads to progressive, non-healing disease (4, 5) . Since then, animal models of leishmaniasis have continued to be used to characterize and understand many important nuances of the adaptive immune system. Despite these many advances in understanding immunologic concepts broadly, our understanding of the immune 50 response to Leishmania spp. specifically is evolving to reflect greater nuances and complexities (6) . Further, current treatment options for leishmaniasis remain prolonged, expensive, have variable efficacy, and significant side effects presenting an urgent need for novel therapeutics (7) . In order to investigate these effectively, it is paramount to have optimal laboratory techniques for assessing disease progression in animals accurately, reproducibly, and under a 55 variety of experimental conditions. Methods to monitor disease progression during Leishmania infection in cutaneous animal models have traditionally relied on measuring footpad swelling and using a limiting dilution assay (LDA) to quantify parasite burden (8) . While LDA remains a reliable and sensitive technique for quantifying parasite burden, these assays are labor intensive, can be technically 60 challenging, and take several weeks to obtain final results. Recent advances employing genetic manipulation of parasites to express live reporter molecules such as mCherry or luciferase allow advanced monitoring of the parasite in real time and over a long-time course; however, they require an additional layer of genetic manipulation on the parasite and often require expensive equipment for visualization (9) (10) (11) . More recently developed protocols utilizing amplification of 65 nucleic acids have been optimized for use in clinical diagnosis. To meet the demands of a clinical diagnostic assay, such as high sensitivity and the ability to discriminate between Leishmania spp., highly variable and multi-copy genes are most commonly used.
However, characteristics for clinical assays for Leishmania detection are not necessarily ideal for use in experimental animal models. The ability to differentiate between different strains 70 is not required when the infecting species is carefully controlled and delivered during experimental infection. Additionally, the use of multi-copy genes which are known to be present in regions of relative genomic plasticity, may change during the course of infection. This at best adds unpredictable variation to the assay and at worst confounds the change by inducing a systematic change across only certain experimental conditions (12) . Finally, it is particularly 75 important to select genes without an active role in disease, as any studies to further understand these or related pathways are subject to the risk of mutations or gene copy expansions rendering PCR at these sites unable to accurately compare across experimental conditions.
Recently, several efforts have been made to standardize lab protocols for detection and quantification of parasites from clinical isolates (13, 14) . However, similar comparative studies 80 that emphasize assay traits optimized for experimental models of infection are lacking. Here we report a real time PCR (RT-PCR) assay based on amplification of a single-copy, housekeeping
Leishmania RNA binding protein (DRBD3) that is optimal for animal model studies. With touchdown cycling parameters, we were able to achieve a sensitivity of 100 fg per reaction which rivals most described PCR protocols for Leishmania quantification. Use of this assay in 85 the future will facilitate studies elucidating mechanisms of immunity to Leishmania spp. and in monitoring efficacy of novel pharmaceutical interventions.
Results

RT-PCR assay design for the Leishmania RNA binding protein, DRBD3. 90
To design an RT-PCR assay with optimal characteristics for quantification of Leishmania parasite burden in experimental models, we first sought to identify a single copy gene essential to the parasite, but less likely to be actively involved in evasion of host defense. For this we chose putative Leishmania RNA binding protein (DRBD3), present in a single-copy on chromosome 4.
The gene is classified as the double RNA binding domain 3 protein based on homology with 95 DRBD3 in Trypanosoma brucei. Studies in T. brucei have identified a consensus binding sequence in the 3'UTR of mRNA transcripts and suggest that DRBD3 plays a role in modulating stress response (15, 16) ; however, there have been no functional studies of this protein in Leishmania spp. to date. The L. major entry for DRBD3 (LmjF.04.1170) on TriTrypDB indicates that the gene is constitutively expressed between parasite life-cycle stages, is not under immune 100 pressure, and has minimal sequence variation between species (17). RNA-seq experiments in both L. major and L. amazonensis have demonstrated little to no change in expression of this gene between the promastigote and amastigote stage consistent with the characteristics of a constitutively expressed housekeeping gene (18) (19) (20) . Additionally, there were no identified epitopes in the Immune Epitope Database (IEDB) corresponding to DRBD3 peptides, suggesting 105 that it is not likely to be influenced by host immune pressure (21) . To verify the homology of DRBD3 between Leishmania spp. we used the sequence from L. major Sd. as a reference, and used NCBI blast software to identify all related sequences. This blast search yielded 11 hits of protein coding genomic DNA within the genus Leishmania. Using ClustalOmega we then created a multisequence alignment, and in combination with NCBI Primer Blast tool designed 110 primers over a highly-conserved region ( Figure 1A ). Both primers have complete conservation at 18 out of 20 nucleotides. This design allows using a single set of primers to PCR amplify a stable, housekeeping gene that is likely to be applicable across a broad range of Leishmania spp.
The assay was then validated with DNA from cultured L. major promastigotes. With touchdown PCR cycling parameters, one distinct product is visible by ethidium bromide staining, 115 which corresponds with a single product by melt curve analysis at 84.4C ( Figure 1B -C). Based on a standard curve extending across six orders of magnitude from 1x10 7 fg -100 fg of parasite DNA per reaction, the PCR had an average efficiency of 100.8% (96.98-104.7, 95%CI, n=6) ( Figure 1D ). The assay can detect DNA above this, but is no longer within the linear range.
Therefore, we successfully developed a novel touch-down based PCR assay for a single-copy, 120 housekeeping gene in Leishmania spp. that is able to efficiently detect as low as 100 fg of parasite DNA per reaction.
Validation of DRBD3 RT-PCR in vivo
We then tested the assay's ability to monitor parasite burden in the murine model of 125 cutaneous leishmaniasis. Wildtype C57BL6 mice were inoculated subcutaneously with 2x10 6 cultured promastigotes in the left hind footpad. At 1 day and 34 days post infection, DNA was isolated from the infected and uninfected footpads as well as the corresponding popliteal lymph nodes.
The assay was able to accurately monitor parasite burden over this course of infection. 130
Reactions with DNA from uninfected footpads and non-draining lymph nodes, included as negative controls, did not amplify a single product at the corresponding melt temperature we report that this assay successfully monitors Leishmania parasite burden in a mouse model of cutaneous leishmaniasis. 145
Comparison of DRBD3 RT-PCR assay to other targets for quantification of Leishmania spp.
infection in animal models
We systematically compared the characteristics of the DRBD3 assay to other RT-PCR assays. A wide variety of assays for Leishmania detection by PCR with diverse targets and 150 characteristics have been described; though, most have been optimized from the perspective of clinical diagnostics.
The most commonly used assays target multicopy genes. This produces advantages in regards to lower limits of detection and the potential to discriminate between species but come at the cost of uncertainty in gene stability at these plastic regions of the genome. 18s rRNA is 155 present in up to 166 copies per parasite (22, 23), ITS-1 at 20-200 (still looking for original paper), minicircle kinetoplast DNA at up to 10,000 copies (24) , and HSP70 at 5-7 (25). These assays report limits of detection as low as 10 fg of parasite DNA per reaction. However, multicopy regions are often under significant change. For example, kDNA is particularly unstable in terms of copy number with reports of it varying between species, strains, and even 160 lifecycle stages (26, 27) .
Single copy genes tend to be in more stable regions of the genome, but report higher limits of detection compared to multicopy gene assays and variable efficiencies between studies.
Glucosephosphate isomerase (GPI), glucose 6 phosphate dehydrogenase (G6PD), Superoxide Dismutase 1 (SODB1) (28), Arginine Permease (AAP3) (29) , and DNA polymerase alpha (30) 165 are all single copy genes for which Leishmania quantification by PCR has been described. The assay for GPI reports a higher limit of detection of 5.6 pg compared to other assays with limits of detection around 10-100 fg per reaction (31). Reported PCR efficiencies for the G6PD assays range from 50.4% to 95.7%. SODB1 and AAP3 described RT-PCR assays have competitive limits of detection and efficiencies (28, 29) ; however, it has become increasingly apparent that 170 both of these genes are important virulence factors. AAP3 is upregulated in response to arginine shortages in host macrophages, and SODB1 deficient L. chagasi parasites demonstrate impaired survival in host macrophages (32) (33) (34) (35) . This raises concern about the reliability of the assays during experimental manipulation; particularly in light of Leishmania spp. regulating gene expression through copy number variation (36) . 175
Amplifying the gene target DNA polymerase alpha has similar characteristics to the DRBD3 assay. It is another example of single copy gene, which can be amplified at high efficiency with a limit of detection of 100 fg (37, 38) . Therefore, for monitoring parasite burden accurately and precisely in animal models, the DRBD3 RT-PCR assay and the DNA polymerase alpha assay (38) fulfill the optimal characteristics. 180
Discussion
Animal models of leishmaniasis have proven to be valuable in understanding basic immunological concepts, and will be critical in future drug development programs to control this neglected tropical disease. The ability to accurately monitor parasite survival and replication in Table 1 . Comparison of described targets for RT-PCR based quantification of parasite burden in humans and animals. these models is paramount to properly understanding the biology of infection and monitoring the 185 effectiveness of novel therapeutic interventions. The development of RT-PCR assays for parasite quantification has been widespread for clinical applications; however, there is no standardized RT-PCR protocol that is optimized specifically for use in animal models. Here we developed a novel touchdown RT-PCR assay of the single copy housekeeping gene, DRBD3, which has a limit of detection that rivals existing protocols while not being subject to changes in sequence or 190 copy number that multicopy genes or genes required for virulence would be subject to.
Accurate measurement of parasite burden by RT-PCR is important for distinguishing between host and parasite mediated pathology. Disease progression of Leishmania animal models is traditionally done by a combination of measuring footpad thickness or directly measuring parasites through limiting dilution assays. Measuring the inflammation that results 195 from infection by swelling at the site of inoculation is a valuable way to monitor severity of disease, but it is unable to distinguish between damage caused by overgrowth of the parasite and damage caused by dysregulated host derived inflammation. Studies showing that parasite growth does not perfectly correlate with lesion size, demonstrate the importance of distinguishing between parasite and host mediated pathology (37, 39) . This is particularly relevant in the 200 context of leishmaniasis where it is well documented that distinct disease manifestations are caused by both extremes of this spectrum (40). Limiting dilution assays are useful for enumerating parasite burden, but are costly in terms of time and resources. Using a RT-PCR approach to amplify parasite DNA allows determination of parasite burden in as little as 2-4 hours instead of waiting approximately a week for parasites to grow in the LDA. 205
The single copy gene DRBD3 is highly conserved across Leishmania spp., and the primers used in this assay bind to a region of DNA over which 90% of the residues are completely conserved. However, it should be noted that the divergence of the 2 nucleotide positions occurs at the division between the Leishmania leishmania and Leishmania viannia subgenera. The primers reported here are 100% conserved within the leishmania subgenus. 210
Within the viannia subgenus, the sequences are also 100% conserved, and are only altered at two sites between the two genera for each primer. We postulate that the primers are also likely to work with high efficiency for parasites in the viannia subgenus, or the assay would be easily adaptable to the viannia subgenus with a second set of specific primers. The DRBD3 RT-PCR assay for Leishmania quantification is therefore also likely to be a robust assay for labs in that 215 validation of the assay one time will allow for use in a wide range of studies modeling parasites with distinct disease phenotypes and from diverse geographic and evolutionary backgrounds.
Careful consideration of protocols used to quantify parasite burden in experimental models of leishmaniasis is essential to fully understand host-parasite interactions and for assessing the efficacy of novel therapeutic interventions. The DRBD3 assay described here will 220 allow for consistent detection of parasites in an unbiased manner with a low limit of detection, facilitating discoveries in basic science and improvements in leishmaniasis treatment.
Materials and Methods
Multisequence alignment and sequence Logo 225
Traits of the DRBD3 gene were analyzed in TriTrypDB using the L. major Fd reference sequence (LmjF.04.1170) (17). The reference sequence used in NCBI Blast tool to identify homologous sequences was based on the L. major SD75.1 sequence in order to correspond with the parasite DNA used to validate the assay in this study. The 11 identified homologous genomic DNA sequences were downloaded and aligned using ClustalOmega (41) . The WebLogo tool was 230 used to generate a sequence logo based on this alignment ( http://weblogo.berkeley.edu/) (42).
Primer design
Primers were designed using Primer-BLAST software (43) . The gene for DRBD3 in the Leishmania major (MHOM/SN/74/Seidman) was input. Five pairs of primers with similar melt temperatures were initially tested. After amplification by conventional PCR, 3 of these primer 235 pairs resulted in non-specific amplification as detected by ethidium bromide detection in a 1% agarose gel. Based on this initial screen, the primers reported in Figure 1B were then used to amplify wildtype L. major (MHOM/SN/74/Seidman) promastigote DNA as described below. Total parasite DNA was calculated by first using the Ct for each reaction to interpolate 250 the fg of parasite DNA per 100ng of total DNA relative to the standard curve included on each 96-well plate. DNA (fg per reaction) was then multiplied by the factor used to dilute each sample to 100ng per PCR reaction in order to get total parasite DNA (fg) per tissue harvested.
RT-PCR protocol for parasite quantification
Parasites and culture conditions
Leishmania major (MHOM/SN/74/Seidman) were obtained from BEI (BEI reference# 255 48819). Parasites were maintained in M199 media supplemented with 10% heat inactivated FBS and 0.2% hemin. Cultures were maintained by inoculating a new 10mL culture with 200ul of previous culture every 5 days. Infections in mice were performed with parasites that had been passaged less than 3 times in vitro.
Mouse infections 260
Wildtype C57BL6 mice from Jackson were maintained in the Duke Laboratory Animal Resource (DLAR). All studies are approved under Duke University IACUC protocol A200-15-07. L. major (MHOM/SN/74/Seidman) parasites were prepared by washing 5 day old culture of promastigotes with Hanks Buffered Salt Solution (HBSS), counting by hemocytometer, and resuspending at 2 x 10 7 parasties per 50µl of HBSS. A 27G 1/2 mL with permanently attached 265 needle was used to inoculate the left hind footpad with 50µl of promastigote suspension. Mice were monitored at least twice weekly to track lesion development.
DNA was obtained using the Qiagen DNeasy Blood and Tissue Kit (Cat # 69504). In brief, tissue from the infected footpads and draining popliteal lymph node of each mouse was harvested. The contralateral footpad and lymph node was taken from each mouse to monitor for 270 contamination. Tissue was placed into a clean 1.5mL microcentrifuge tube. To 180µl of buffer ATL and 20µl of proteinase K was added to each tube prior to homogenizing the tissue with a bead beater and incubating samples at 37C overnight before proceeding as indicated by manufacturer instructions. DNA quantity and quality was assessed using the Take3 application on a Synergy H1 BioTek plate reader prior to use in the RT-PCR assay described. 275
